TECENTRIQ HYQEVO

Serial Number 97338551
733

Registration Progress

Application Filed
Mar 30, 2022
Under Examination
Jul 25, 2023
Approved for Publication
May 30, 2023
Published for Opposition
May 30, 2023
Registered

Attorney Assistance

Statement of Use Due - Extension 4 Granted
Due: Jan 25, 2026 181 days

Trademark Image

TECENTRIQ HYQEVO

Basic Information

Serial Number
97338551
Filing Date
March 30, 2022
Published for Opposition
May 30, 2023
Drawing Code
4

Status Summary

Current Status
Active
Status Code
733
Status Date
Jul 21, 2025
Application
Pending
Classes
005

Rights Holder

Genentech, Inc.

03
Address
1 DNA Way
South San Francisco, CA 94080

Ownership History

Genentech, Inc.

Original Applicant
03
South San Francisco, CA

Genentech, Inc.

Owner at Publication
03
South San Francisco, CA

Legal Representation

Attorney
Jelena Libby

USPTO Deadlines

Next Deadline
181 days remaining
Statement of Use Due - Extension 4 Granted
Due Date
January 25, 2026
Extension Available
Until July 25, 2024

Application History

39 events
Date Code Type Description Documents
Jul 22, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 21, 2025 EX4G S SOU EXTENSION 4 GRANTED Loading...
Jul 21, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 21, 2025 EXT4 S SOU EXTENSION 4 FILED Loading...
Jul 21, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 3, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 22, 2025 EX3G S SOU EXTENSION 3 GRANTED Loading...
Jan 22, 2025 EXT3 S SOU EXTENSION 3 FILED Loading...
Jan 22, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 9, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 9, 2024 EX2G S SOU EXTENSION 2 GRANTED Loading...
Jul 9, 2024 EXT2 S SOU EXTENSION 2 FILED Loading...
Jul 9, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 10, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 8, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 8, 2024 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jan 8, 2024 EXT1 S SOU EXTENSION 1 FILED Loading...
Jul 25, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
May 30, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
May 30, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
May 10, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Apr 24, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Apr 20, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Apr 20, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Apr 20, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Apr 19, 2023 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Apr 19, 2023 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Apr 19, 2023 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Apr 19, 2023 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Loading...
Oct 25, 2022 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Oct 25, 2022 GNRT F NON-FINAL ACTION E-MAILED Loading...
Oct 25, 2022 CNRT R NON-FINAL ACTION WRITTEN Loading...
Oct 24, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 25, 2022 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Aug 25, 2022 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Aug 25, 2022 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Loading...
Aug 25, 2022 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Apr 5, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Apr 2, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations, applied subcutaneously and containing atezolizumab, for the treatment of oncological disorders and diseases

Classification

International Classes
005